J Neurol Surg B Skull Base 2021; 82(S 02): S65-S270
DOI: 10.1055/s-0041-1725492
Presentation Abstracts
Poster Abstracts

Meta-analysis of Adjuvant Radiotherapy for Intracranial Atypical and Malignant Meningiomas

Authors

  • Ansley Unterberger

    1   David Geffen School of Medicine at UCLA, Los Angeles, California, United States

  • Thien Nguyen

    2   Department of Neurosurgery at UCLA, Los Angeles, California, United States

  • Courtney Duong

    2   Department of Neurosurgery at UCLA, Los Angeles, California, United States

  • Aditya Kondajji

    1   David Geffen School of Medicine at UCLA, Los Angeles, California, United States

  • Daniel Kulinich

    1   David Geffen School of Medicine at UCLA, Los Angeles, California, United States

  • Isaac Yang

    2   Department of Neurosurgery at UCLA, Los Angeles, California, United States
Further Information
Also available at
 
 

Objective: In this study, we investigated the effect of adjuvant radiotherapy (ART) postsurgery on survival outcomes compared with surgery alone for high-grade meningiomas.

Methods: PRISMA guidelines were a foundation for our literature review. We screened the PubMed database for studies reporting overall survival (OS), progression-free survival (PFS), and tumor recurrence for intracranial, primary AMs and MMs treated with surgery + ART or surgery alone. Fixed and random effect models compared tumor control rate for AM aforementioned groups.

Results: Mean 5-year PFS was 76.9% for AM (surgery + ART) and 55.9% for AM (surgery alone) patients. Mean 5-year OS was 81.3 and 74% for AM (surgery + ART) and AM (surgery alone) groups, respectively. Overall, the mean 5-year PFS for aggregated high-grade meningiomas AM + MM (surgery + ART) was 67.6%. Fixed effect models revealed tumor control rate as 76% for AM (surgery + ART) and 69% for AM (surgery alone) groups.

Conclusion: Our analysis suggests that (surgery + ART) may increase PFS, OS, and tumor control rates in high-grade meningiomas. However, further studies involving surgery + ART should be conducted to fully evaluate the ideal radiosurgical candidate, modality, and dosage.


No conflict of interest has been declared by the author(s).

Publication History

Article published online:
12 February 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany